Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation.

Ikegami M, Scoville EA, Grant S, Korfhagen T, Brondyk W, Scheule RK, Whitsett JA.

Chest. 2007 Nov;132(5):1447-54. Epub 2007 Oct 9.

PMID:
17925426
2.

Surfactant protein D deficiency increases lung injury during endotoxemia.

King BA, Kingma PS.

Am J Respir Cell Mol Biol. 2011 May;44(5):709-15. doi: 10.1165/rcmb.2009-0436OC. Epub 2010 Jul 16.

3.

Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb.

Ikegami M, Carter K, Bishop K, Yadav A, Masterjohn E, Brondyk W, Scheule RK, Whitsett JA.

Am J Respir Crit Care Med. 2006 Jun 15;173(12):1342-7. Epub 2006 Mar 23.

4.

Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D.

Kingma PS, Zhang L, Ikegami M, Hartshorn K, McCormack FX, Whitsett JA.

J Biol Chem. 2006 Aug 25;281(34):24496-505. Epub 2006 Jun 20. Erratum in: J Biol Chem. 2006 Dec 15;281(50):38968.

5.

Surfactant protein-d inhibits lung inflammation caused by ventilation in premature newborn lambs.

Sato A, Whitsett JA, Scheule RK, Ikegami M.

Am J Respir Crit Care Med. 2010 May 15;181(10):1098-105. doi: 10.1164/rccm.200912-1818OC. Epub 2010 Feb 4.

6.

Protective effects of surfactant protein D treatment in 1,3-β-glucan-modulated allergic inflammation.

Fakih D, Pilecki B, Schlosser A, Jepsen CS, Thomsen LK, Ormhøj M, Watson A, Madsen J, Clark HW, Barfod KK, Hansen S, Marcussen N, Jounblat R, Chamat S, Holmskov U, Sorensen GL.

Am J Physiol Lung Cell Mol Physiol. 2015 Dec 1;309(11):L1333-43. doi: 10.1152/ajplung.00090.2015. Epub 2015 Oct 2.

PMID:
26432866
7.

Surfactant protein D alters allergic lung responses in mice and human subjects.

Brandt EB, Mingler MK, Stevenson MD, Wang N, Khurana Hershey GK, Whitsett JA, Rothenberg ME.

J Allergy Clin Immunol. 2008 May;121(5):1140-1147.e2. doi: 10.1016/j.jaci.2008.02.011. Epub 2008 Mar 19.

8.

Enhanced clearance of surfactant protein D during LPS-induced acute inflammation in rat lung.

Herbein JF, Wright JR.

Am J Physiol Lung Cell Mol Physiol. 2001 Jul;281(1):L268-77.

9.

Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors.

Yamazoe M, Nishitani C, Takahashi M, Katoh T, Ariki S, Shimizu T, Mitsuzawa H, Sawada K, Voelker DR, Takahashi H, Kuroki Y.

J Biol Chem. 2008 Dec 19;283(51):35878-88. doi: 10.1074/jbc.M807268200. Epub 2008 Nov 5.

10.

Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide.

McIntosh JC, Swyers AH, Fisher JH, Wright JR.

Am J Respir Cell Mol Biol. 1996 Oct;15(4):509-19.

PMID:
8879185
11.

Neither SP-A nor NH2-terminal domains of SP-A can substitute for SP-D in regulation of alveolar homeostasis.

Zhang L, Ikegami M, Korfhagen TR, McCormack FX, Yoshida M, Senior RM, Shipley JM, Shapiro SD, Whitsett JA.

Am J Physiol Lung Cell Mol Physiol. 2006 Aug;291(2):L181-90. Epub 2006 Feb 24.

12.

Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.

Mahajan L, Madan T, Kamal N, Singh VK, Sim RB, Telang SD, Ramchand CN, Waters P, Kishore U, Sarma PU.

Int Immunol. 2008 Aug;20(8):993-1007. doi: 10.1093/intimm/dxn058. Epub 2008 Jul 14.

13.

Genomic organization of the mouse gene for lung surfactant protein D.

Lawson PR, Perkins VC, Holmskov U, Reid KB.

Am J Respir Cell Mol Biol. 1999 May;20(5):953-63.

PMID:
10226065
14.

Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor.

Knapp S, von Aulock S, Leendertse M, Haslinger I, Draing C, Golenbock DT, van der Poll T.

J Immunol. 2008 Mar 1;180(5):3478-84.

15.

Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide.

Hoogerwerf JJ, de Vos AF, Levi M, Bresser P, van der Zee JS, Draing C, von Aulock S, van der Poll T.

Crit Care Med. 2009 Feb;37(2):619-25. doi: 10.1097/CCM.0b013e31819584f9.

PMID:
19114879
16.

Aerosolized endotoxin is immediately bound by pulmonary surfactant protein D in vivo.

van Rozendaal BA, van de Lest CH, van Eijk M, van Golde LM, Voorhout WF, van Helden HP, Haagsman HP.

Biochim Biophys Acta. 1999 Aug 30;1454(3):261-9.

17.

Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice.

Atochina EN, Gow AJ, Beck JM, Haczku A, Inch A, Kadire H, Tomer Y, Davis C, Preston AM, Poulain F, Hawgood S, Beers MF.

J Infect Dis. 2004 Apr 15;189(8):1528-39. Epub 2004 Mar 30.

18.

Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans.

Hoogerwerf JJ, de Vos AF, Bresser P, van der Zee JS, Pater JM, de Boer A, Tanck M, Lundell DL, Her-Jenh C, Draing C, von Aulock S, van der Poll T.

Am J Respir Crit Care Med. 2008 Jul 1;178(1):34-41. doi: 10.1164/rccm.200708-1261OC. Epub 2008 Apr 10.

PMID:
18403723
19.

NOS2 is critical to the development of emphysema in Sftpd deficient mice but does not affect surfactant homeostasis.

Knudsen L, Atochina-Vasserman EN, Guo CJ, Scott PA, Haenni B, Beers MF, Ochs M, Gow AJ.

PLoS One. 2014 Jan 21;9(1):e85722. doi: 10.1371/journal.pone.0085722. eCollection 2014.

20.

Surfactant protein-D regulates the postnatal maturation of pulmonary surfactant lipid pool sizes.

Ikegami M, Grant S, Korfhagen T, Scheule RK, Whitsett JA.

J Appl Physiol (1985). 2009 May;106(5):1545-52. doi: 10.1152/japplphysiol.91567.2008. Epub 2009 Mar 5.

Items per page

Supplemental Content

Write to the Help Desk